Aktuellt
SENASTE
Redeye embraces the FDA Fast Track Designation for the evaluation process of Sedana Medical’s solution for inhaled sedation. We emphasise several significant optionalities to its review process, which it could now be eligible for. The designation underpins the unmet medical need we see for this specific patient group but does not render any reconsiderations to our fair value range at current.
LÄS MER
